Cite
HARVARD Citation
Hartung, H. et al. (2022). Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Multiple sclerosis. pp. 429-440. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hartung, H. et al. (2022). Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Multiple sclerosis. pp. 429-440. [Online].